Intensity Therapeutics to Participate in the 34th Annual Roth Conference
/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a phase 2 clinical-stage biotechnology company focused on the discovery and development of...
Stay updated with breaking news from Rx Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity"), a phase 2 clinical-stage biotechnology company focused on the discovery and development of...
/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), today announced that the Company's 2021 Annual Meeting of Stockholders (the "Annual Meeting") will...
/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), today announced that the Company's 2021 Annual Meeting of Stockholders (the "Annual Meeting") will...
/PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects,...
/PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), announced that the Company's Annual Meeting of Stockholders (the "Annual Meeting") scheduled for...